Flow cytometry, invented in the 1950s, uses antibodies linked to fluorescent probes to detect cell surface and intracellular proteins. Although able to achieve single-cell sensitivity, the method is ...

Please provide your email address to receive an email when new articles are posted on . Imaging mass cytometry appeared feasible and allowed for a more comprehensive overview of triple-negative breast ...

WMIC 2019 WorkshopOn Friday, September 6, Fluidigm will host an IMC workshop at the World Molecular Imaging Congress. Andrew Quong, PhD, Chief Science Officer of Fluidigm, will lead the session and ...

Applying social network algorithms to mass cytometry data from single cancer cells leads to more accurate predictions of patient outcomes. You have full access to this article via your institution.

The successful use of CyTOF® technology for mass cytometry has resulted in its application in over 100 clinical research trials and a bibliography fast approaching 1,000 peer-reviewed publications.

Flow cytometry is one of the most powerful single-cell analytical techniques. With the current generation of instruments, 30 or more parameters can be measured simultaneously. In traditional ...

What motivated you to develop the ACE technique? One of the limitations of mass cytometry is its low sensitivity. To reach the detection limit, the target needs multiple copies of the antibody tag ...

The Francis Crick Institute’s flow cytometry core has shown at ELRIG 2025 how a heterogeneous fleet of spectral, mass and ...

Under the direction of Hyun-Sung Lee, M.D., Ph.D., the Systems Onco-Immunology Laboratory (SOIL) uses and develops innovative methods within the context of multi-omics technologies to investigate ...

Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used single-cell "mass cytometry" to examine healthy human bone marrow, measuring 34 parameters ...

We spoke to Stanford University’s Wendy Fantl and Veronica Gonzalez about their novel use of mass cytometry (CyTOF) to identify never-before-seen cell subtypes in high-grade serous ovarian cancer ...